Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Sci ; 113(6): 1488-1497, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38280723

ABSTRACT

Phage therapy has regained value as a potential alternative and a complementary anti-infective approach to antibiotics in the fight against bacterial pathogens. Due to their host specificity, non-pathogenic nature for humans, and low production cost, phages offer an effective opportunity for utilization in healthcare, agriculture, and food preservation. Well-defined storage conditions are essential for commercialization and dissemination of phage usage. For this purpose, in our study, after the isolation and characterization of two different phages, one lytic and the other lysogenic; storage and shelf-life studies of phages were evaluated in a presence of various protectants (glycerol, sodium azide, DMSO with chloroform) and without any protectant during 8-month period at four different temperatures. The short-time stability of the lytic P. syringae phage and lysogenic MRSA phage, which were determined by STEM analysis to belong to the Straboviridae and Siphoviridae families, respectively were also examined for the different temperatures and the pH levels ranging from 1.0 to 14.0. This study revealed the storage-model of phages that exhibit distinct lifecycles, for the first time and provided a theoretical basis for development and application of phages, has yielded valuable findings contributing to understanding of phage biology.


Subject(s)
Bacteriophages , Bacteriophages/physiology , Temperature , Glycerol/chemistry , Glycerol/pharmacology , Lysogeny , Hydrogen-Ion Concentration , Sodium Azide , Pseudomonas syringae/virology , Pseudomonas syringae/drug effects , Chloroform/chemistry , Methicillin-Resistant Staphylococcus aureus/virology , Methicillin-Resistant Staphylococcus aureus/drug effects , Protective Agents/pharmacology , Phage Therapy/methods
2.
Int J Biol Macromol ; 258(Pt 2): 129060, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38159698

ABSTRACT

World Health Organization (WHO) warns about antimicrobial resistance (AMR) considered as the most serious threats to global health, food security, and development. There are various efforts for elimination of this serious issue. These efforts include education of individuals, new policies, development of new antimicrobials and new materials for effective delivery. Novel drug delivery systems with ability of local and on-demand delivery are one of the promising approaches for prevention of AMR. In this regard, a pH-responsive antibiotic delivery system based on pH-responsive poly(ß-amino ester) (PBAE) and enzyme responsive hyaluronic acid (HA). The polymeric nanocomplexes were obtained via electrostatic complexation of PBAE and HA in the presence of a model antibiotics, colistin and vancomycin. The particle sizes at pH 7.4 were determined in the range of 131-730 nm and 120-400 nm by DLS and STEM, respectively. When pH was switched from 7.4 to 5.5, the hydrodynamic diameter increased 2.5-32 fold. The drug release performances were tested using FITC-labeled antibiotics via fluorescence spectroscopy. The nanocomplexes released the drugs more at pH 5.5 compared to pH 7.4. Antibacterial activity of the system was evaluated on various bacteria. The nanocomplex loaded with the antibiotics exhibited significantly greater efficacy against E. coli and S. aureus.


Subject(s)
Anti-Bacterial Agents , Hyaluronic Acid , Polymers , Humans , Anti-Bacterial Agents/chemistry , Hyaluronic Acid/chemistry , Staphylococcus aureus , Esters , Escherichia coli , Hydrogen-Ion Concentration
SELECTION OF CITATIONS
SEARCH DETAIL